GENI vs. ENFN, MGNI, BASE, SMR, TBLA, ETWO, MODN, PDFS, HLIT, and FORTY
Should you be buying Genius Sports stock or one of its competitors? The main competitors of Genius Sports include Enfusion (ENFN), Magnite (MGNI), Couchbase (BASE), NuScale Power (SMR), Taboola.com (TBLA), E2open Parent (ETWO), Model N (MODN), PDF Solutions (PDFS), Harmonic (HLIT), and Formula Systems (1985) (FORTY). These companies are all part of the "computer and technology" sector.
Genius Sports (NYSE:GENI) and Enfusion (NYSE:ENFN) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.
Enfusion has a net margin of 3.45% compared to Genius Sports' net margin of -20.71%. Enfusion's return on equity of 10.30% beat Genius Sports' return on equity.
Enfusion has lower revenue, but higher earnings than Genius Sports. Genius Sports is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.
Genius Sports presently has a consensus price target of $9.25, indicating a potential upside of 78.23%. Enfusion has a consensus price target of $9.33, indicating a potential downside of 0.92%. Given Genius Sports' stronger consensus rating and higher probable upside, analysts plainly believe Genius Sports is more favorable than Enfusion.
Genius Sports received 42 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 61.73% of users gave Genius Sports an outperform vote while only 17.02% of users gave Enfusion an outperform vote.
81.9% of Genius Sports shares are owned by institutional investors. Comparatively, 81.1% of Enfusion shares are owned by institutional investors. 16.6% of Genius Sports shares are owned by company insiders. Comparatively, 39.2% of Enfusion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Genius Sports had 5 more articles in the media than Enfusion. MarketBeat recorded 5 mentions for Genius Sports and 0 mentions for Enfusion. Genius Sports' average media sentiment score of 0.09 beat Enfusion's score of 0.00 indicating that Genius Sports is being referred to more favorably in the media.
Genius Sports has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500. Comparatively, Enfusion has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.
Summary
Genius Sports beats Enfusion on 10 of the 18 factors compared between the two stocks.
Get Genius Sports News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GENI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genius Sports Competitors List
Related Companies and Tools
